Cited by 110Dementia and Cognitive Impairment ResearchPsychological Testing and AssessmentAlzheimer's disease research and treatments

The DOI matches its Crossref record; 18 of the 20 references it cites were found in a registry or an index.

The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease

Open access

Rossetti, Heidi C., Munro Cullum, C., Hynan, Linda S., Lacritz, Laura H.·2010·Alzheimer Disease & Associated Disorders

DOI 10.1097/wad.0b013e3181b76415PMC PMC2920638

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To establish the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychologic battery as a valid measure of cognitive progression in Alzheimer disease (AD) by deriving annualized CERAD Total Change Scores and corresponding confidence intervals in AD and controls from which to define clinically meaningful change. METHOD: Subjects included 383 normal control (NC) and 655 AD subjects with serial data from the CERAD registry database. Annualized CERAD Total Change Scores were derived and Reliable Change Indexes (RCIs) calculated to establish statistically reliable change values. CERAD Change Scores were compared with annualized change scores from the Mini-Mental State Examination (MMSE), Clinical Dementia Rating Scale (CDR) Sum of Boxes, and Blessed Dementia Rating Scale (BDRS). RESULTS: For the CERAD Total Score, the AD sample showed significantly greater decline than the NC sample over the 4-year interval, with AD subjects declining an average of 22.2 points compared with the NCs' improving an average 2.8 points from baseline to last visit [Group x Time interaction [F(4,1031)=246.08, P<0.001)]. By Visit 3, the majority of AD subjects (65.2%) showed a degree of cognitive decline that fell outside the RCI. CERAD Change Scores significantly correlated (P<0.001) with MMSE (r=-0.66), CDR (r=-0.42), and BDRS (r=-0.38) change scores. CONCLUSION: Results support the utility of the CERAD Total Score as a measure of AD progression and provide comparative data for annualized change in CERAD Total Score and other summary measures.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1097/wad.0b013e3181b76415

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Clinical significance: A statistical approach to defining meaningful change in psychotherapy research.
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery
Welsh, K. A., Butters, N., Mohs, R. C., Beekly, D., Edland, S., Fillenbaum, G., & Heyman, A. (1994) · Neurology · doi:10.1212/wnl.44.4.609 · Cited by 951
Clinical Dementia Rating (CDR)
Gauthier, S. G. (2001) · CRC Press eBooks · doi:10.3109/9780203213896-34 · Cited by 696
Individual change after epilepsy surgery: Practice effects and base-rate information.
Chelune, G. J., Naugle, R. I., Lüders, H. O., Sedlak, J., & Awad, I. A. (1993) · Neuropsychology · doi:10.1037/0894-4105.7.1.41 · Cited by 599
Detection and Staging of Dementia in Alzheimer's Disease
Welsh-Bohmer, K. A. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290030008 · Cited by 473
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
Morris, J. C., Edland, S., Clark, C., Galasko, D., Koss, E., Mohs, R., van Belle, G., Fillenbaum, G., & Heyman, A. (1993) · Neurology · doi:10.1212/wnl.43.12.2457 · Cited by 441

Show all 20 references

Sorted by citations

Trajectory of Cognitive Decline After Incident Stroke
Levine, D. A., Galecki, A. T., Langa, K. M., Unverzagt, F. W., Kabeto, M. U., Giordani, B., & Wadley, V. G. (2015) · JAMA · doi:10.1001/jama.2015.6968 · Cited by 497
Evidence-Based Indicators of Neuropsychological Change in the Individual Patient: Relevant Concepts and Methods
Duff, K. (2012) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acr120 · Cited by 452
Sex differences in cognitive decline among US adults
Levine, D. A., Gross, A. L., Briceño, E. M., Tilton, N., Giordani, B. J., Sussman, J. B., Hayward, R. A., Burke, J. F., Hingtgen, S., Elkind, M. S. V., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.0169 · Cited by 440
Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
Huang, S., Zhang, Y.-R., Guo, Y., Du, J., Ren, P., Wu, B., Feng, J., Initiative, A. D. N., Cheng, W., & Yu, J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13789 · Cited by 305
Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease
Hsu, J., Wei, Y., Toh, C., Hsiao, I., Lin, K., Yen, T., Liao, M., & Ro, L. (2022) · Annals of Neurology · doi:10.1002/ana.26516 · Cited by 261
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Shi, H., Koronyo, Y., Rentsendorj, A., Regis, G. C., Sheyn, J., Fuchs, D.-T., Kramerov, A. A., Ljubimov, A. V., Dumitrascu, O. M., Rodriguez, A. R., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02134-w · Cited by 230
Gait analysis with wearables predicts conversion to Parkinson disease
Din, S. D., Elshehabi, M., Galna, B., Hobert, M. A., Warmerdam, E., Suenkel, U., Brockmann, K., Metzger, F. G., Hansen, C., Berg, D., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25548 · Cited by 211
Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores
Williams, M., Storandt, M., Roe, C. M., & Morris, J. C. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.005 · Cited by 160
Retinal pathological features and proteome signatures of Alzheimer’s disease
Koronyo, Y., Rentsendorj, A., Mirzaei, N., Regis, G. C., Sheyn, J., Shi, H., Barrón, E., Cook‐Wiens, G., Rodriguez, A., Medeiros, R., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02548-2 · Cited by 162
Early detection of Alzheimer’s disease with a total score of the German CERAD
Ehrensperger, M. M., Berres, M., Taylor, K. I., & Monsch, A. U. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710000822 · Cited by 96
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies
Ramnarain, D., Aupers, E., Oudsten, B. L. D., Oldenbeuving, A. W., Vries, J. D., & Pouwels, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1981289 · Cited by 104
Blood Pressure and Cognitive Decline Over 8 Years in Middle-Aged and Older Black and White Americans
Levine, D. A., Galecki, A. T., Langa, K. M., Unverzagt, F. W., Kabeto, M. U., Giordani, B., Cushman, M., McClure, L. A., Safford, M. M., & Wadley, V. G. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12062 · Cited by 91
Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials
Borland, E., Edgar, C., Stomrud, E., Cullen, N., Hansson, O., & Palmqvist, S. (2022) · Neurology · doi:10.1212/wnl.0000000000200817 · Cited by 83
[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies
Rinne, J. O., Wong, D. F., Wolk, D. A., Leinonen, V., Arnold, S. E., Buckley, C. J., Smith, A. P. L., McLain, R. W., Sherwin, P. F., Farrar, G., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1051-z · Cited by 84
Resting-state prefrontal EEG biomarkers in correlation with MMSE scores in elderly individuals
Choi, J.-M., Ku, B. U., You, Y. G., Jo, M., Kwon, M., Choi, Y., Jung, S., Ryu, S., Park, E., Go, H.-Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46789-2 · Cited by 89
Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations
Webster, L., Groskreutz, D., Grinbergs‐Saull, A., Howard, R. J., O'Brien, J. T., Mountain, G. A., Banerjee, S., Woods, B. T., Perneczky, R., Lafortune, L., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21260 · Cited by 75
The CERAD Neuropsychological Assessment Battery Total Score Detects and Predicts Alzheimer Disease Dementia with High Diagnostic Accuracy
Wolfsgruber, S., Jessen, F., Wiese, B., Stein, J., Bickel, H., Mösch, E., Weyerer, S. B., Werle, J., Pentzek, M., Fuchs, Â., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.08.021 · Cited by 71
CERAD (Consortium to Establish a Registry for Alzheimer’s Disease) Neuropsychology Assessment Battery: 35 Years and Counting
Fillenbaum, G. G., & Mohs, R. C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230026 · Cited by 78
Transcranial ultrasound neuromodulation for epilepsy: A pilot safety trial
Bubrick, E. J., McDannold, N. J., Orozco, J., Mariano, T. Y., Rigolo, L., Golby, A. J., Tie, Y., & White, P. J. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.11.013 · Cited by 56
CERAD Neuropsychological Compound Scores are Accurate in Detecting Prodromal Alzheimer's Disease: A Prospective AddNeuroMed Study
Paajanen, T. I., Hänninen, T., Tunnard, C., Hallikainen, M., Mecocci, P., Sobów, T., Tsolaki, M., Vellas, B. J., Lovestone, S., & Soininen, H. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-122110 · Cited by 48
An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients
Wong, D. F., Moghekar, A., Rigamonti, D., Brašić, J. R., ROUSSET, O. G., Willis, W. D., Buckley, C. J., Smith, A. P. L., Gok, B., Sherwin, P. F., et al. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0583-x · Cited by 45
Can leisure activities slow dementia progression in nursing home residents? A cluster-randomized controlled trial
Cheng, S., Chow, P. K. Y., Song, Y., Yu, E. C. S., & Lam, J. (2014) · International Psychogeriatrics · doi:10.1017/s1041610213002524 · Cited by 43
The Effectiveness of Reality Orientation in the Treatment of Alzheimer’s Disease
Camargo, C. H. F., Justus, F. F., & Retzlaff, G. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514568004 · Cited by 43
The ROSMAP project: aging and neurodegenerative diseases through omic sciences
Pérez-González, A. P., García-Kroepfly, A. L., Pérez-Fuentes, K. A., García-Reyes, R. I., Solis-Roldan, F. F., Alba-González, J. A., Lemus, E. H., & de Anda‐Jáuregui, G. (2024) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2024.1443865 · Cited by 49
CERAD practice effects and attrition bias in a dementia prevention trial
Mathews, M. J., Abner, E. L., Caban‐Holt, A., Kryscio, R. J., & Schmitt, F. A. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213000367 · Cited by 36
Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment
Roalf, D. R., Initiative, A. D. N., Quarmley, M., Mechanic-Hamilton, D. J., Wolk, D. A., Arnold, S. E., & Moberg, P. J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160259 · Cited by 38
Trajectory of Cognitive Decline After Sepsis
Wang, H. E., Kabeto, M., Gray, M., Wadley, V. G., Muntner, P., Judd, S. E., Safford, M. M., Kempker, J. A., & Levine, D. A. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004897 · Cited by 36
Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study
Hallikainen, I. T., Hänninen, T., zu Fraunberg, M. V. U., Hongisto, K., Välimäki, T. H., Hiltunen, A., Karppi, P., Sivenius, J., Soininen, H. S., & Koivisto, A. M. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213000653 · Cited by 35
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease
Davis, M. R., Robinson, E., Koronyo, Y., Salobrar‐García, E., Rentsendorj, A., Gaire, B. P., Mirzaei, N., Kayed, R., Sadun, A. A., Ljubimov, A. V., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01935-y · Cited by 34
Neural Correlates Associated With Cognitive Decline in Late-Life Depression
Wang, L., Potter, G. G., Krishnan, R., Dolcos, F., Smith, G. S., & Steffens, D. C. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31823e2cc7 · Cited by 34
Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status
Shi, H., Mirzaei, N., Koronyo, Y., Davis, M. R., Robinson, E., Braun, G. M., Jallow, O., Rentsendorj, A., Ramanujan, V. K., Fert‐Bober, J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02760-8 · Cited by 33
Cognitive frailty: A comprehensive clinical paradigm beyond cognitive decline
Cozza, M., & Boccardi, V. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102738 · Cited by 30
Comprehensive Model for Physical and Cognitive Frailty: Current Organization and Unmet Needs
Lauretani, F., Longobucco, Y., Pellegrini, F. F., Iorio, A. M. D., Fazio, C. D., Federici, R., Gallini, E., Porta, U. L., Ravazzoni, G., Roberti, M. F., et al. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.569629 · Cited by 30
The Current Landscape of Prevention Trials in Dementia
Lee, J., Howard, R. S., & Schneider, L. S. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01236-5 · Cited by 30
Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene
Aguirre-Acevedo, D. C., Jaimes-Barragán, F., Henao, E., Tirado, V., Muñoz, C., Reiman, E. M., Tariot, P. N., Langbaum, J. B., & Lopera, F. (2016) · International Psychogeriatrics · doi:10.1017/s1041610215001660 · Cited by 25
Mental Illness, Not Obesity Status, is Associated with Food Insecurity Among the Elderly in the Health and Retirement Study
Brostow, D. P., Gunzburger, E. C., Abbate, L. M., Brenner, L. A., & Thomas, K. S. (2019) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2019.1565901 · Cited by 25
Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer’s disease and FDG-PET findings
Hsu, J., Hsu, W., Chang, C.-C., Lin, K., Hsiao, I., Fan, Y., & Bai, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-01193-6 · Cited by 23
Deep learning based low-cost high-accuracy diagnostic framework for dementia using comprehensive neuropsychological assessment profiles
Choi, H.-S., Choe, J. Y., Kim, H., Han, J. W., Chi, Y. K., Kim, K., Hong, J., Kim, T. H., Kim, T. H., Yoon, S., et al. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0915-z · Cited by 24
Initial Adaptation of the General Cognitive Assessment Battery by Cognifit™ for Bulgarian Older Adults
Yaneva, A., Massaldjieva, R., & Mateva, N. G. (2021) · Experimental Aging Research · doi:10.1080/0361073x.2021.1981096 · Cited by 21
Amyloid pathology and synaptic loss in pathological aging
Gkanatsiou, E., Nilsson, J., Toomey, C. E., Vrillon, A., Kvartsberg, H., Portelius, E., Zetterberg, H., Blennow, K., Brinkmalm, A., Lashley, T., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15487 · Cited by 23
Long-term exposure to air pollution and cognitive function in older adults: a systematic review and meta-analysis
McLachlan, J., Cox, S. R., Pearce, J. R., & Hernández, M. D. C. V. (2023) · Frontiers in Environmental Health · doi:10.3389/fenvh.2023.1205443 · Cited by 23
A normative study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population
Han, J. Y., Seo, E. H., Yi, D., Sohn, B. K., Choe, Y. M., Byun, M. S., Choi, H. J., Kim, S. G., Park, S. Y., Kim, J. W., et al. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214001379 · Cited by 23
Retinal thickness predicts the risk of cognitive decline over five years
Eppenberger, L. S., Li, C., Wong, D. W. K., Tan, B., Garhöfer, G., Hilal, S., Chong, E. J. Y., Toh, A. Q., Venketasubramanian, N., Chen, C., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01627-0 · Cited by 19
Cognitive variability, brain aging, and cognitive decline in late‐life major depression
Manning, K. J., Preciado-Piña, J., Wang, L., Fitzgibbon, K. E., Chan, G., & Steffens, D. C. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5465 · Cited by 19
Reduced RNA adenosine-to-inosine editing in hippocampus vasculature associated with Alzheimer’s disease
Crooke, P. S., Tossberg, J. T., Heinrich, R. M., Porter, K. P., & Aune, T. M. (2022) · Brain Communications · doi:10.1093/braincomms/fcac238 · Cited by 16
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Ibáñez, L., Cruchaga, C., & Fernández, M. V. (2021) · Genes · doi:10.3390/genes12081247 · Cited by 20
Associations Between Stroke Type, Ischemic Stroke Subtypes, and Poststroke Cognitive Trajectories
Levine, D. A., Whitney, R. T., Ye, W., Briceño, E. M., Gross, A. L., Giordani, B., Sussman, J. B., Lazar, R. M., Howard, V. J., Aparicio, H. J., et al. (2025) · Stroke · doi:10.1161/strokeaha.124.047640 · Cited by 19
Sleep duration and cognitive function among older adults with chronic kidney disease: results from the National Health and Nutrition Examination Survey (2011–2014)
Warsame, F., Chu, N. M., Hong, J., Mathur, A., Crews, D. C., Bayliss, G. P., Segev, D. L., & McAdams‐DeMarco, M. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac325 · Cited by 16
Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer’s Disease: Kuopio ALSOVA Study
Hallikainen, I. T., Koivisto, A. M., Paajanen, T. I., Hiltunen, A., Karppi, P., Vanhanen, M., Välimäki, T. H., Herukka, S., Soininen, H. S., & Hänninen, T. (2012) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000338231 · Cited by 16
Association of Plasma Oligomerized Beta Amyloid with Neurocognitive Battery Using Korean Version of Consortium to Establish a Registry for Alzheimer’s Disease in Health Screening Population
Lee, J., Choi, Y. K., Chung, S., Yoon, D. H., Choi, S. H., Kang, S. M., Seo, D., & Park, K. (2020) · Diagnostics · doi:10.3390/diagnostics10040237 · Cited by 15
A Comparison of Operational Definitions for Mild Cognitive Impairment
Polcher, A. A., Wolfsgruber, S., Peters, O., Frölich, L., Wiltfang, J., Kornhuber, J., Hüll, M., Rüther, E., Lewczuk, P., Maier, W., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215548 · Cited by 17
The Effectiveness of Reality Orientation Therapy in the Treatment of Parkinson Disease Dementia
Camargo, C. H. F., Ladeira, M. A., Serpa, R. A., Jobbins, V. A., Filho, C. R. P., Welling, L. C., & Teive, H. A. G. (2018) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317518802461 · Cited by 14
Novel image–novel location object recognition task sensitive to age-related cognitive decline in nondemented elderly
Haley, G. E., Berteau-Pavy, F., Berteau-Pavy, D., & Raber, J. (2011) · AGE · doi:10.1007/s11357-010-9204-2 · Cited by 14
Objective cognitive functioning in patients with stress-related disorders: a cross-sectional study using remote digital cognitive testing
Föyen, L. F., Sennerstam, V., Kontio, E., Lekander, M., Hedman‐Lagerlöf, E., & Lindsäter, E. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05048-5 · Cited by 13
Genome-wide screen to identify genetic loci associated with cognitive decline in late-life depression
Steffens, D. C., Garrett, M. E., Soldano, K. L., McQuoid, D. R., Ashley‐Koch, A. E., & Potter, G. G. (2020) · International Psychogeriatrics · doi:10.1017/s1041610220001143 · Cited by 13
Association rule learning in neuropsychological data analysis for Alzheimer’s disease
Happawana, K., & Diamond, B. J. (2021) · Journal of Neuropsychology · doi:10.1111/jnp.12252 · Cited by 12
Does personality moderate the efficacy of physical and cognitive training interventions? A 12-month randomized controlled trial in older adults
Kekäläinen, T., Terracciano, A., Tirkkonen, A., Savikangas, T., Hänninen, T., Neely, A. S., Sipilä, S., & Kokko, K. (2022) · Personality and Individual Differences · doi:10.1016/j.paid.2022.111957 · Cited by 16
A systematic review of validity procedures used in neuropsychological batteries.
Pawlowski, J., Segabinazi, J. D., Wagner, F., & Bandeira, D. R. (2013) · Psychology & Neuroscience · doi:10.3922/j.psns.2013.3.09 · Cited by 12
Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests
Jun, H., Cho, S. K., Yoong, J., & Mattke, S. (2021) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.20.0082 · Cited by 11
Modern care for patients with Alzheimer disease: rationale for early intervention.
Galluzzi, K. E., Appelt, D. M., & Balin, B. J. (2010) · PubMed · Cited by 10
CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease
Paajanen, T. I., Hänninen, T., Aitken, A. P., Hallikainen, M., Westman, E., Wahlund, L., Sobów, T., Mecocci, P., Tsolaki, M., Vellas, B. J., et al. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000356725 · Cited by 13
Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
Camargo, C. H. F., Bronzini, A., Tolentino, E. D. S., Medyk, C., & Schultz-Pereira, G. L. (2018) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20180003 · Cited by 11
Prevalence of neurocognitive disorders 5 years after elective orthopaedic surgery
Atkins, K. J., SILBERT, B. S., Scott, D. A. H., & Evered, L. A. (2024) · Anaesthesia · doi:10.1111/anae.16365 · Cited by 10
Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial
Kutzsche, J., Cosma, N. C., Kauselmann, G., Fenski, F., Bieniek, C., Bujnicki, T., Pils, M., Bannach, O., Willbold, D., & Peters, O. (2025) · Nature Communications · doi:10.1038/s41467-025-59295-z · Cited by 10
Careful neuropsychological testing reveals a novel genetic marker,GSTO1*C, linked to the pre-stage of Alzheimer's disease
Umlauf, E., Rappold, E., Schiller, B., Fuchs, P., Rainer, M. K., Wolf, B., & Zellner, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9773 · Cited by 11
Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS1
Levine, D. A., Gross, A. L., Briceño, E. M., Tilton, N., Whitney, R. T., Han, D., Giordani, B., Sussman, J. B., Hayward, R. A., Burke, J. F., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220366 · Cited by 9
Predicting Mental Decline Rates in Mild Cognitive Impairment From Baseline MRI Volumetric Data
Nguyen, X. V., Candemir, S., Erdal, B. S., White, R., & Prevedello, L. M. S. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000406 · Cited by 8
Modeling common Alzheimer’s disease with high and low polygenic risk in human iPSC: A large-scale research resource
Maguire, E., Winston, J., Ellwood, S. H., O’Donoghue, R., Shaw, B., Castillo-Morales, A., Keat, S., Evans, A., Marshall, I. J., Luckcuck, L., et al. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102570 · Cited by 7
Magnetoencephalography Brain Signatures Relate to Cognition and Cognitive Reserve in the Oldest-Old: The EMIF-AD 90 + Study
Griffa, A., Legdeur, N., Badissi, M., van den Heuvel, M. P., Stam, C. J., Visser, P. J., & Hillebrand, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.746373 · Cited by 9
Interpreting reliable change on the Spanish-language NIH toolbox cognition battery
Karr, J. E., Mindt, M. R., & Iverson, G. L. (2021) · Applied Neuropsychology Adult · doi:10.1080/23279095.2021.2011726 · Cited by 9
Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer’s Disease over a Three-Year Period: Kuopio ALSOVA Study
Törmälehto, S., Martikainen, J. A., Väätäinen, S. T., Hallikainen, I. T., Hallikainen, M., Bell, J. S., Koivisto, A. M., & and on the behalf of the ALSOVA study group (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150092 · Cited by 6
The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study
Hallikainen, I., Martikainen, J., Lin, P.-J., Cohen, J. T., Lahoz, R., Välimäki, T., Hongisto, K., Väätäinen, S., Vanhanen, M., Neumann, P., et al. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000369159 · Cited by 5
Dementia detection using the deep convolution neural network method
Janakiramaiah, B., & Kalyani, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822226-3.00007-6 · Cited by 6
Antidepressant Effects of a Multimodal Group Therapy Program for Mild Dementia: A Retrospective Evaluation of Clinical Routine Data
Bartels, C., Abdel‐Hamid, M., Wiltfang, J., Schneider, A., & Belz, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220578 · Cited by 5
Linking higher amyloid beta 1‐38 (Aβ(1‐38)) levels to reduced Alzheimer's disease progression risk
Schneider, L., Freiesleben, S. D., van Breukelen, G., Wang, X., Brosseron, F., Heneka, M. T., Teipel, S. J., Kleineidam, L., Stark, M., Roy‐Kluth, N., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14545 · Cited by 3
Association Between Omega-3 Supplement Use and Cognitive Function in Korean Older Adults: An 8-Year Longitudinal Cohort Study
Lee, W. M., Ryu, S. I., Lim, M.-N., Han, J. W., Bae, J. B., Kim, T. H., Kwak, K. P., Kim, B., Kim, S. G., Kim, J. L., et al. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100739 · Cited by 2
Neuroplastic and Pro-cognitive Effects of Granulocyte Colony Stimulating Factor in Healthy Adults: A Pilot Study
Wang, S., Kang, D. W., Kim, H., Park, S., & Lim, H. K. (2023) · Psychiatry Investigation · doi:10.30773/pi.2023.0150 · Cited by 2
Telomere length, in vivo Alzheimer’s disease pathologies and cognitive decline in older adults
Jung, J. H., Byun, M. S., Yi, D., Ahn, H., Lee, J. H., Lee, J.-S., Lee, H., Lee, J., Kim, Y. K., Lee, Y., et al. (2024) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2024-334314 · Cited by 2
Assessing the Preparedness of the Australian Health Care System Infrastructure for an Alzheimer's Disease-Modifying Therapy
Baxi, S. M., Girosi, F., & Liu, J. (2019) · RAND Corporation eBooks · doi:10.7249/rr2891 · Cited by 2
Consortium to Establish a Registry on Alzheimer’s Disease
Vandermorris, S., Strauss, E., & Sherman, E. M. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-57111-9_534 · Cited by 2
Predicting Therapy Outcomes in Patients With Stress-Related Disorders: Protocol for a Predictive Modeling Study
Föyen, L. F., Sennerstam, V., Kontio, E., Flygare, O., Boman, M., & Lindsäter, E. (2025) · JMIR Research Protocols · doi:10.2196/65790 · Cited by 1
Long-Term Effects of Cognitive Behavioral Therapy on Sickness Absence and Cognitive Functioning in Patients with Stress-Related Disorders: Secondary Results from a Randomized Clinical Trial
Föyen, L. F., Sennerstam, V., Kontio, E., Lekander, M., Hedman‐Lagerlöf, E., & Lindsäter, E. (2025) · Psychotherapy and Psychosomatics · doi:10.1159/000547266 · Cited by 1
Validation of cognitive and psychosocial tools in Kenya: findings from the LOSHAK feasibility pilot
Mani, S. S., Riang’a, R. M., Nagarajan, N., Ngugi, A. K., Mwangi, E. M., Gichu, M., Mwangala, P. N., Miguel, E. A., Walker, M., Langa, K. M., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-24918-z · Cited by 1
Bicarbonate, blood urea nitrogen and cognitive function among us older adults, NHANES 2011–2014
Jiao, D., Li, M., Wu, L., Zhang, W., Dou, J., Li, S., Zhao, Q., Yang, C., Nie, J., Ding, Y., et al. (2025) · Psychology Health & Medicine · doi:10.1080/13548506.2025.2597470 · Cited by 1
Old Age Dementias: Factors Associated with Dementia Progression Rate. Part 2
Mikhaylova, N. M. (2020) · Psikhiatriya · doi:10.30629/2618-6667-2020-18-4-93-113 · Cited by 1
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
Emdina, A., Hermann, P., Varges, D., Nuhn, S., Goebel, S., Bunck, T., Maass, F., Schmitz, M., Llorens, F., Kruse, N., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051259 · Cited by 1
The Relationship Between Cognition Function and Three Factors Based on Big Data and ANOVA Text
Li, X. (2020) · International Conference on Big Data and Social Sciences (ICBDSS) · doi:10.1109/icbdss51270.2020.00013 · Cited by 1
Factores de riesgo de la enfermedad de Alzheimer Risk factors of the Alzheimer's disease
Romero, J. S., Dra, I., González, M. G., Marante, J. P. D., & Llibre, J. J. (2014)
#neverforget - Photobiomodulation Against Alzheimer's Disease: A Systematic Review
Enengl, J., & Dungel, P. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1906.02501
Neurofilament Light Chain als Prädiktor kognitiven Abbaus bei Mild Cognitive Impairment
Berens, M. (2021) · doi:10.53846/goediss-8625
Consortium to Establish a Registry on Alzheimer’s Disease
Vandermorris, S., Strauss, E., & Sherman, E. M. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-56782-2_534-2
Idiopathisches Parkinson Syndrom und a-Synuclein im Liquor: Bio- und Prognosemarker für Kognition, Krankheitsverlauf und depressive Symptomatik?
Emdina, A. (2022) · doi:10.53846/goediss-9491
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in elderlyPreprint
Schalkamp, A., Lerche, S., Wurster, I., Röeben, B., Zimmermann, M., Fries, F. L., von Thaler, A., Eschweiler, G. W., Gasser, T., Maetzler, W., et al. (2022) · medRxiv · doi:10.1101/2022.11.18.22282498
USING A REVERSE VISUALLY GUIDED REACHING TASK TO DISTINGUISH BETWEEN HEALTHY AGING AND EARLY ALZHEIMER’S DISEASE
Woolman, B. (2024) · doi:10.37099/mtu.dc.etdr/1718
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participants
Schalkamp, A., Lerche, S., Wurster, I., Röeben, B., Zimmermann, M., Fries, F. L., von Thaler, A., Eschweiler, G. W., Maetzler, W., Berg, D., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1447944
The extended Czech uniform data set 2.0 neuropsychological battery: Reliable change indices and logistic regression analysis
Čihák, M., Bezdíček, O., Nikolai, T., Georgi, H. S., & Kopeček, M. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251392270 · Cited by 1
Additional file 1 of Objective cognitive functioning in patients with stress-related disorders: a cross-sectional study using remote digital cognitive testing
Franke Föyen, L., Sennerstam, V., Kontio, E., Lekander, M., Hedman-Lagerlöf, E., & Lindsäter, E. (2023) · Figshare · doi:10.6084/m9.figshare.23902993
Estrogènes et pathologies neuropsychiatriques chez les femmes âgées
Ryan, J. L. (2010) · theses.fr (ABES) · doi:10.70675/b3559bf2z9a55z4f80zb317zb0d042d05a5c
Alternative clinical trial designs to find a clinically important effect size of blood pressure-lowering on cognitive impairment and dementia
Levine, D. A., Hayward, R. A., Sussman, J. B., Whitney, R. T., Gałecki, A. T., Briceño, E. M., Gross, A. L., Giordani, B., Elkind, M. S. V., Gaskin, D. J., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261430953
Associations between apathy and global cognition in a 5‐year follow‐up of individuals with Alzheimer's disease
Loukola, H., Kärkkäinen, M., Selander, T. A., Honkalampi, K. M., Koivisto, A. M., & Saari, T. T. (2026) · Journal of Neuropsychology · doi:10.1111/jnp.70044

Authors: Rossetti, H. C., Munro Cullum, C., Hynan, L. S., & Lacritz, L. H.
Affiliations: The University of Texas Southwestern Medical Center (US)
Corresponding author: Rossetti, Heidi C.
Hynan, Linda S.
Lacritz, Laura H.
ORCID: Rossetti, Heidi C.
Hynan, Linda S.
Lacritz, Laura H.
Venue: Alzheimer Disease & Associated Disorders
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-04
Volume: 24
Issue: 2
Pages: 138-142
ISSN: 0893-0341 (ISSN-L)
DOI: 10.1097/wad.0b013e3181b76415
PMC: PMC2920638
OpenAlex: W1981940800
Cited by: 110
References: 20
Citations by year: 2026: 12 · 2025: 12 · 2024: 8 · 2023: 7 · 2022: 12 · 2021: 12 · 2020: 8 · 2019: 6 · 2018: 5 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 5
FWCI: 3.28
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Alzheimer Disease & Associated Disorders (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (P30AG012300, P30AG-12300)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: Alzheimer's disease, cognitive decline, disease progression, reliable change index, Mini-Mental State Examination, Clinical Dementia Rating, healthy controls, clinical outcome measures
MeSH terms: Aged, Alzheimer Disease, Female, Humans, Male, Neuropsychological Tests, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks